A detailed history of Segall Bryant & Hamill, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 62,621 shares of HAE stock, worth $4.32 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
62,621
Previous 62,214 0.65%
Holding current value
$4.32 Million
Previous $5.15 Million 2.22%
% of portfolio
0.07%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$72.45 - $91.58 $29,487 - $37,273
407 Added 0.65%
62,621 $5.03 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $5.05 Million - $6.06 Million
62,214 New
62,214 $5.15 Million
Q2 2021

Aug 12, 2021

SELL
$51.81 - $118.56 $3.4 Million - $7.79 Million
-65,691 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$111.01 - $139.48 $6.52 Million - $8.19 Million
-58,689 Reduced 47.19%
65,691 $7.29 Million
Q4 2020

Feb 12, 2021

SELL
$88.75 - $119.95 $734,672 - $992,946
-8,278 Reduced 6.24%
124,380 $14.8 Million
Q3 2020

Nov 13, 2020

BUY
$75.65 - $93.58 $6.71 Million - $8.3 Million
88,719 Added 201.91%
132,658 $11.6 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $3.09 Million - $4.33 Million
36,423 Added 484.61%
43,939 $3.94 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $558,739 - $915,599
7,516 New
7,516 $749,000
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $3.45 Million - $4.4 Million
-38,368 Closed
0 $0
Q2 2018

Aug 08, 2018

SELL
$71.53 - $95.75 $2.01 Million - $2.69 Million
-28,067 Reduced 42.25%
38,368 $0
Q1 2018

May 16, 2018

SELL
$60.72 - $74.41 $7.27 Million - $8.91 Million
-119,679 Reduced 64.3%
66,435 $0
Q4 2017

Feb 15, 2018

SELL
$44.96 - $58.99 $565,416 - $741,858
-12,576 Reduced 6.33%
186,114 $0
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $8.02 Million - $8.92 Million
198,690
198,690 $0

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.